FH
UBX

Financial Harvest’s Unity Biotechnology UBX Stock Holding History

Financial Harvest’s Portfolio UBX Stock Details UBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-205,270
Closed -$8.46M – 101
2025
Q1 		$8.46M Buy
+205,270
New +$371K 6.98% 6

Other funds holding UBX

AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
FFVM
Founders Fund V Management San Francisco, California $2.16M AUM 77.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Financial Harvest's UBX Position: Q2 2025 in Review

Financial Harvest sold out of Unity Biotechnology (UBX) in Q2 2025, closing a stake of 205,270 shares — an estimated $8.46M sold.

Financial Harvest first reported a position in UBX in Q1 2025 and held it in 1 quarter. The position peaked at $8.46M in Q1 2025. 35 funds tracked by Wall St. Rank hold UBX as of Q2 2025.

  • Financial Harvest reported no remaining Unity Biotechnology position as of Q2 2025 after selling out during the quarter.
  • Financial Harvest sold 205,270 Unity Biotechnology shares in Q2 2025, an estimated $8.46M.
  • Financial Harvest first reported a position in Unity Biotechnology in Q1 2025 and held it in 1 quarter.
  • Financial Harvest's Unity Biotechnology position peaked at $8.46M in Q1 2025.
  • 35 funds tracked by Wall St. Rank held Unity Biotechnology as of Q2 2025.

Based on Financial Harvest's 13F filing for Q2 2025, filed 14 Jul 2025.